Small-molecule hormones: Molecular mechanisms of action

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Puzianowska Kuznicka, Monika ^a,b   Pawlik Pachucka, Eliza ^a,b   Owczarz, Magdalena ^b   Budzińska, Monika ^b   Polosak, Jacek ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DEXAMETHASONE; HORMONE; HORMONE RECEPTOR; PRASTERONE; RNA; STEROID HORMONE; TATA BINDING PROTEIN; TATA BINDING PROTEIN RELATED FACTOR; TRANSCRIPTION FACTOR;

CHROMATIN; GENE TARGETING; GENOME ANALYSIS; HORMONE ACTION; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; MITOCHONDRION; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 84875425186     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/601246     Document Type: Review

References (275)

1. Suzuki S., Shigematsu S., Inaba H., Takei M., Takeda T., Komatsu M., Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options. Endocrine 2011 40 3 366 371 10.1007/s12020-011-9538-2
2. Ferrara A. M., Onigata K., Ercan O., Woodhead H., Weiss R. E., Refetoff S., Homozygous thyroid hormone receptor b gene mutations in resistance to thyroid hormone: three new cases and review of the literature. Journal of Clinical Endocrinology and Metabolism 2012 97 4 1328 1336 10.1210/jc.2011-2642
3. Kannan S., Safer J. D., Finding the right balance between resistance and sensitivity: a review of the cardiac manifestations of the syndrome of resistance to thyroid hormone and the implications for treatment. Endocrine Practice 2012 18 2 252 255 10.4158/EP11075.RA
4. van Mullem A., van Heerebeek R., Chrysis D., Clinical phenotype and mutant TRa1. The New England Journal of Medicine 2012 366 15 1451 1453
5. Turowska O., Nauman A., Pietrzak M., Popławski P., Master A., Nygard M., Bondesson M., Tanski Z., Puzianowska-Kuznicka M., Overexpression of E2F1 in clear cell renal cell carcinoma: a potential impact of erroneous regulation by thyroid hormone nuclear receptors. Thyroid 2007 17 11 1039 1048 2-s2.0-36749004292 10.1089/thy.2007.0075 (Pubitemid 350207757)
6. Lu C., Cheng S. Y., Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis. Steroids 2011 76 9 885 891 2-s2.0-79959898331 10.1016/j.steroids.2011.03.016
7. Rosen M. D., Privalsky M. L., Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. Journal of Thyroid Research 2011 361304 10.4061/2011/361304
8. Lu C., Mishra A., Zhu Y. J., Meltzer P., Cheng S. Y., Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis. American Journal of Cancer Research 2011 1 2 168 191
9. Rosen M. D., Chan I. H., Privalsky M. L., Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas. Molecular Endocrinology 2011 25 8 1311 1325 2-s2.0-79960997523 10.1210/me.2010-0420
10. Chen Z., Wang Z. Y., Chen S. J., Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis. Pharmacology and Therapeutics 1997 76 1-3 141 149 2-s2.0-0031278165 10.1016/S0163-7258(97)00090-9 (Pubitemid 28078567)
11. Olasz J., Juhász A., Remenár E., RAR β 2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Oncology Reports 2007 18 1 105 112
12. van Neerven S., Kampmann E., Mey J., RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases. Progress in Neurobiology 2008 85 4 433 451 2-s2.0-48349094743 10.1016/j.pneurobio.2008.04.006
13. Nguyen T. M., Adiceam P., Kottler M. L., Guillozo H., Rizk-Rabin M., Brouillard F., Lagier P., Palix C., Garnier J. M., Garabedian M., Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D. Journal of Bone and Mineral Research 2002 17 9 1728 1737 2-s2.0-0036708163
14. Aljubeh J. M., Wang J., Al-Remeithi S. S., Malloy P. J., Feldman D., Report of two unrelated patients with hereditary vitamin D resistant rickets due to the same novel mutation in the vitamin D receptor. Journal of Pediatric Endocrinology and Metabolism 2011 24 9-10 793 799
15. Malloy P. J., Zhou Y., Wang J., Hiort O., Feldman D., Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor. Journal of Bone and Mineral Research 2011 26 11 2710 2718 10.1002/jbmr.484
16. Massart F., Marcucci G., Brandt M. L., Pharmacogenetics of bone treatments: the VDR and ER α gene story. Pharmacogenomics 2008 9 6 733 746 2-s2.0-48949119313 10.2217/14622416.9.6.733
17. Malloy P. J., Feldman D., The role of vitamin D receptor mutations in the development of alopecia. Molecular and Cellular Endocrinology 2011 347 1-2 90 96 10.1016/j.mce.2011.05.045
18. Köstner K., Denzer N., Müller C. S. L., Klein R., Tilgen W., Reichrath J., The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Research 2009 29 9 3511 3536 2-s2.0-68549118801
19. Field S., Newton-Bishop J. A., Melanoma and vitamin D. Molecular Oncology 2011 5 2 197 214 2-s2.0-79955479273 10.1016/j.molonc.2011.01.007
20. Welsh J., Cellular and molecular effects of vitamin D on carcinogenesis. Archives of Biochemistry and Biophysics 2012 523 1 107 114 10.1016/j.abb.2011. 10.019
21. Wu S., Sun J., Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery Medicine 2011 11 59 325 335 10.1038/nrc3038
22. Zúñiga S., Firrincieli D., Housset C., Chignard N., Vitamin D and the vitamin D receptor in liver pathophysiology. Clinics and Research in Hepatology and Gastroenterology 2011 35 4 295 302 2-s2.0-79955042823 10.1016/j.clinre.2011.02.003
23. Visser M. E., Kropman E., Kranendonk M. E., Koppen A., Hamers N., Stroes E. S., Kalkhoven E., Monajemi H., Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR γ mutation (Y151C). Diabetologia 2011 54 7 1639 1644 2-s2.0-79959730637 10.1007/s00125-011-2142-4
24. Jeninga E. H., Kalkhoven E., Central players in inherited lipodystrophies. Trends in Endocrinology and Metabolism 2010 21 10 581 588 2-s2.0-77957221736 10.1016/j.tem.2010.06.006
25. Vigouroux C., Caron-Debarle M., Le Dour C., Magré J., Capeau J., Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. International Journal of Biochemistry and Cell Biology 2011 43 6 862 876 2-s2.0-79955907495 10.1016/j.biocel.2011.03.002
26. Anbalagan M., Huderson B., Murphy L., Rowan B. G., Post-translational modifications of nuclear receptors and human disease. Nuclear Receptor Signaling 2012 10, article e001
27. Robbins G. T., Nie D., PPARg, bioactive lipids, and cancer progression. Frontiers in Bioscience 2012 17 1816 1834 10.2741/4021
28. Wang N., Yin R., Liu Y., Mao G., Xi F., Role of peroxisome proliferator-activated receptor- γ in atherosclerosis: an update. Circulation Journal 2011 75 3 528 535 2-s2.0-79952337610 10.1253/circj.CJ-11- 0060
29. Martin H., Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutation Research 2010 690 1-2 57 63 2-s2.0-77955251736 10.1016/j.mrfmmm.2009.09.009
30. Fahmi H., Martel-Pelletier J., Pelletier J. P., Kapoor M., Peroxisome proliferator-activated receptor gamma in osteoarthritis. Modern Rheumatology 2011 21 1 1 9 2-s2.0-79951942686 10.1007/s10165-010-0347-x
31. Jacobs E. T., Martínez M. E., Campbell P. T., Conti D. V., Duggan D., Figueiredo J. C., Haile R. W., LeRoy E. C., Poynter J. N., Thompson P. A., Baron J. A., Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2010 31 8 1412 1416 2-s2.0-77955367456 10.1093/carcin/bgq127
32. Hsieh C. H., Pei D., Hung Y. J., Hsiao F. C., Association between retinoid-X receptor g genetic polymorphisms and diabetic retinopathy. Genetics and Molecular Research 2011 10 4 3545 3551 10.4238/2011.December.5.4
33. Shi H., Yu X., Li Q., Association between PPAR γ and RXR α gene polymorphism and metabolic syndrome risk: a case-control study of a Chinese Han population. Archives of Medical Research 2012 43 3 233 242 10.1016/j.arcmed.2012.03.006
34. Barone I., Brusco L., Fuqua S. A. W., Estrogen receptor mutations and changes in downstream gene expression and signaling. Clinical Cancer Research 2010 16 10 2702 2708 2-s2.0-77952397929 10.1158/1078-0432.CCR-09-1753
35. Valentin M. D., da Silva S. D., Privat M., Alaoui-Jamali M., Bignon Y. J., Molecular insights on basal-like breast cancer. Breast Cancer Research and Treatment 2012 134 1 21 30 10.1007/s10549-011-1934-z
36. Eiermann W., Bergh J., Cardoso F., Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design. Breast 2012 21 1 20 26 10.1016/j.breast.2011.09.006
37. Le Romancer M., Poulard C., Cohen P., Sentis S., Renoir J. M., Corbo L., Cracking the estrogen receptor's posttranslational code in breast tumors. Endocrine Reviews 2011 32 5 597 622 10.1210/er.2010-0016
38. Bulun S. E., Monsavais D., Pavone M. E., Role of estrogen receptor β in endometriosis. Seminars in Reproductive Medicine 2012 30 1 39 45 10.1055/s-0031-1299596
39. Drummond A. E., Fuller P. J., Ovarian actions of estrogen receptor b: an update. Seminars in Reproductive Medicine 2012 30 1 32 38 10.1055/s-0031-1299595
40. Faulds M. H., Zhao C., Dahlman-Wright K., Gustafsson J. Å., The diversity of sex steroid action: regulation of metabolism by estrogen signaling. Journal of Endocrinology 2012 212 1 3 12 10.1530/JOE-11-0044
41. Rajender S., Singh L., Thangaraj K., Phenotypic heterogeneity of mutations in androgen receptor gene. Asian Journal of Andrology 2007 9 2 147 179 2-s2.0-33947246101 10.1111/j.1745-7262.2007.00250.x (Pubitemid 46416577)
42. Galani A., Kitsiou-Tzeli S., Sofokleous C., Kanavakis E., Kalpini-Mavrou A., Androgen insensitivity syndrome: clinical features and molecular defects. Hormones 2008 7 3 217 229 2-s2.0-52449110003
43. Hughes I. A., Davies J. D., Bunch T. I., Pasterski V., Mastroyannopoulou K., MacDougall J., Androgen insensitivity syndrome. The Lancet 2012 380 9851 1419 1428 10.1016/S0140-6736(12)60071-3
44. Saraon P., Jarvi K., Diamandis E. P., Molecular alterations during progression of prostate cancer to androgen independence. Clinical Chemistry 2011 57 10 1366 1375 10.1373/clinchem.2011.165977
45. Kumar R., Atamna H., Zakharov M. N., Bhasin S., Khan S. H., Jasuja R., Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy. Life Sciences 2011 88 13-14 565 571 2-s2.0-79952697937 10.1016/j.lfs.2011.01.021
46. Bergerat J. P., Céraline J., Pleiotropic functional properties of androgen receptor mutants in prostate cancer. Human Mutation 2009 30 2 145 157 2-s2.0-59749095425 10.1002/humu.20848
47. Katsuno M., Banno H., Suzuki K., Adachi H., Tanaka F., Sobue G., Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Advances in Experimental Medicine and Biology 2010 685 64 74 2-s2.0-77955883056 10.1007/978-1-4419-6448-9-6
48. Gottlieb B., Lombroso R., Beitel L. K., Trifiro M. A., Molecular pathology of the androgen receptor in male (in)fertility. Reproductive BioMedicine Online 2005 10 1 42 48 2-s2.0-11944273134 (Pubitemid 40100653)
49. Bulun S. E., Cheng Y. H., Pavone M. E., Xue Q., Attar E., Trukhacheva E., Tokunaga H., Utsunomiya H., Yin P., Luo X., Lin Z., Imir G., Thung S., Su E. J., Kim J. J., Estrogen receptor- β estrogen receptor- α and progesterone resistance in endometriosis. Seminars in Reproductive Medicine 2010 28 1 36 43 2-s2.0-76249101923 10.1055/s-0029-1242991
50. Abid S., Gokral J., Maitra A., Meherji P., Kadam S., Pires E., Modi D., Altered expression of progesterone receptors in testis of infertile men. Reproductive BioMedicine Online 2008 17 2 175 184 2-s2.0-49749122643
51. van Rossum E. F. C., Lamberts S. W. J., Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach. Best Practice and Research 2006 20 4 611 626 2-s2.0-33845235453 10.1016/j.beem.2006.09.005 (Pubitemid 44856488)
52. Nicolaides N. C., Galata Z., Kino T., Chrousos G. P., Charmandari E., The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010 75 1 1 12 2-s2.0-71849112377 10.1016/j.steroids.2009.09.002
53. DeRijk R. H., de Kloet E. R., Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. European Journal of Pharmacology 2008 583 2-3 303 311 2-s2.0-40849117844 10.1016/j.ejphar.2007.11.072
54. Kino T., Chrousos G. P., Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays in Biochemistry 2004 40 137 155 2-s2.0-3142520021 (Pubitemid 38901170)
55. Rafestin-Oblin M. E., Souque A., Bocchi B., Pinon G., Fagart J., Vandewalle A., The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology 2003 144 2 528 533 2-s2.0-0037320545 10.1210/en.2002-220708 (Pubitemid 36205224)
56. Nuclear Receptors Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily. Cell 1999 97 2 161 163 10.1016/S0092-8674(00)80726-6
57. Escriva H., Bertrand S., Laudet V., The evolution of the nuclear receptor superfamily. Essays in Biochemistry 2004 40 11 26 2-s2.0-3142624840 (Pubitemid 38901165)
58. Germain P., Staels B., Dacquet C., Spedding M., Laudet V., Overview of nomenclature of nuclear receptors. Pharmacological Reviews 2006 58 4 685 704 2-s2.0-33751548984 10.1124/pr.58.4.2 (Pubitemid 44833739)
59. Rochette-Egly C., Gaub M. P., Lutz Y., Ali S., Scheuer I., Chambon P., Retinoic acid receptor- β: immunodetection and phosphorylation on tyrosine residues. Molecular Endocrinology 1992 6 12 2197 2209 2-s2.0-0027081543 10.1210/me.6.12.2197 (Pubitemid 23021570)
60. Juge-Aubry C. E., Hammar E., Siegrist-Kaiser C., Pernin A., Takeshita A., Chin W. W., Burger A. G., Meier C. A., Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor by phosphorylation of a ligand-independent trans-activating domain. Journal of Biological Chemistry 1999 274 15 10505 10510 2-s2.0-0033537827 10.1074/jbc.274.15.10505 (Pubitemid 29180929)
61. Nordzell M., Aarnisalo P., Benoit G., Castro D. S., Perlmann T., Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1. Biochemical and Biophysical Research Communications 2004 313 1 205 211 2-s2.0-0346220219 10.1016/j.bbrc.2003.11.079 (Pubitemid 37524044)
62. Rajbhandari P., Finn G., Solodin N. M., Regulation of estrogen receptor N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Molecular and Cellular Biology 2012 32 2 445 457 10.1128/MCB.06073-11
63. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R., Sigler P. B., Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991 352 6335 497 505 2-s2.0-0025780755 10.1038/352497a0 (Pubitemid 21912367)
64. Schwabe J. W. R., Chapman L., Finch J. T., Rhodes D., The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993 75 3 567 578 2-s2.0-0027365669 10.1016/0092-8674(93)90390-C (Pubitemid 23335081)
65. Miyamoto T., Kakizawa T., Ichikawa K., Nishio S. I., Takeda T., Suzuki S., Kaneko A., Kumagai M., Mori J. I., Yamashita K., Sakuma T., Hashizume K., The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors. Molecular and Cellular Endocrinology 2001 181 1-2 229 238 2-s2.0-0035811547 10.1016/S0303-7207(01)00483-X (Pubitemid 32703764)
66. Wurtz J. M., Bourguet W., Renaud J. P., A canonical structure for the ligand-binding domain of nuclear receptors. Nature Structural Biology 1996 3 1 87 94 10.1038/nsb0196-87 (Pubitemid 26023915)
67. Uppenberg J., Svensson C., Jaki M., Bertilsson G., Jendeberg L., Berkenstam A., Crystal structure of the ligand binding domain of the human nuclear receptor PPAR γ Journal of Biological Chemistry 1998 273 47 31108 31112 2-s2.0-0032553542 10.1074/jbc.273.47.31108 (Pubitemid 28533120)
68. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D., Crystal structure of the ligand-binding domain of the human nuclear receptor RXR- α Nature 1995 375 6530 377 382 2-s2.0-0029012163
69. Nayeri S., Kahlen J. P., Carlberg G., The high affinity ligand binding conformation of the nuclear 1,25-dihydroxyvitamin D3 receptor is functionally linked to the transactivation domain 2 (AF-2). Nucleic Acids Research 1996 24 22 4513 4518 2-s2.0-0029911510 10.1093/nar/24.22.4513 (Pubitemid 26388639)
70. Brzozowski A. M., Pike A. C. W., Dauter Z., Hubbard R. E., Bonn T., Engström O., Öhman L., Greene G. L., Gustafsson J. Å., Carlquist M., Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997 389 6652 753 758 2-s2.0-0030667676 10.1038/39645 (Pubitemid 27458965)
71. Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D., Fletterick R. J., A structural role for hormone in the thyroid hormone receptor. Nature 1995 378 6558 690 697 2-s2.0-0029643769
72. Huq M. D. M., Ha S. G., Wei L. N., Modulation of retinoic acid receptor alpha activity by lysine methylation in the DNA binding domain. Journal of Proteome Research 2008 7 10 4538 4545 2-s2.0-55949127661 10.1021/pr800375z
73. La Rosa P., Pesiri V., Leclercq G., Marino M., Acconcia F., Palmitoylation regulates 17 β -estradiol-induced estrogen receptor α degradation and transcriptional activity. Molecular Endocrinology 2012 26 5 762 774 10.1210/me.2011-1208
74. Abdel-Hafiz H. A., Horwitz K. B., Control of progesterone receptor ranscriptional synergy by SUMOylation and deSUMOylation. BMC Molecular Biology 2012 22 13, article 10 10.1186/1471-2199-13-10
75. Chen S., Gulla S., Cai C., Balk S. P., Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. Journal of Biological Chemistry 2012 287 11 8571 8583 10.1074/jbc.M111.325290
76. Anbalagan M., Huderson B., Murphy L., Rowan B. G., Post-translational modifications of nuclear receptors and human disease. Nuclear Receptor Signaling 2012 10, article e001
77. Wallace A. D., Cidlowski J. A., Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. Journal of Biological Chemistry 2001 276 46 42714 42721 2-s2.0-0035900780 10.1074/jbc.M106033200
78. Ciechanover A., Orian A., Schwartz A. L., Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 2000 22 5 442 451 (Pubitemid 30308270)
79. Sengupta S., Wasylyk B., Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes and Development 2001 15 18 2367 2380 2-s2.0-0035883863 10.1101/gad.202201 (Pubitemid 32899741)
80. Wang X., DeFranco D. B., Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Molecular Endocrinology 2005 19 6 1474 1482 2-s2.0-22344452512 10.1210/me.2004-0383 (Pubitemid 41002979)
81. Lonard D. M., Nawaz Z., Smith C. L., O'Malley B. W., The 26S proteasome is required for estrogen receptor- α and coactivator turnover and for efficient estrogen receptor- α transactivation. Molecular Cell 2000 5 6 939 948 2-s2.0-0033638393
82. Deroo B. J., Rentsch C., Sampath S., Young J., DeFranco D. B., Archer T. K., Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Molecular and Cellular Biology 2002 22 12 4113 4123 2-s2.0-0036261563 10.1128/MCB.22.12.4113-4123.2002 (Pubitemid 34556582)
83. Pratt W. B., Galigniana M. D., Morishima Y., Murphy P. J. M., Role of molecular chaperones in steroid receptor action. Essays in Biochemistry 2004 40 41 58 2-s2.0-3142550874 (Pubitemid 38901166)
84. Pratt W. B., Morishima Y., Murphy M., Harrell M., Chaperoning of glucocorticoid receptors. Handbook of experimental pharmacology. 2006 172 111 138 2-s2.0-33645960684
85. Li L., Li Z., Howley P. M., Sacks D. B., E6AP and calmodulin reciprocally regulate estrogen receptor stability. Journal of Biological Chemistry 2006 281 4 1978 1985 2-s2.0-33644855057 10.1074/jbc.M508545200 (Pubitemid 43845784)
86. 2+-induced activation and dimerization of estrogen receptor a by calmodulin. Journal of Biological Chemistry 2012 287 12 9336 9344
87. Sivanandam A., Murthy S., Chinnakannu K., Bai V. U., Kim S. H., Barrack E. R., Menon M., Reddy G. P. V., Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. Journal of Cellular Physiology 2011 226 7 1889 1896 2-s2.0-79955007789 10.1002/jcp.22516
88. La Rosa P., Pesiri V., Leclercq G., Marino M., Acconcia F., Palmitoylation regulates 17 β -estradiol-induced estrogen receptor α degradation and transcriptional activity. Molecular Endocrinology 2012 26 5 762 774 10.1210/me.2011-1208
89. Chatterjee K., Lee J. K., Rentoumis A., Jameson J. L., Negative regulation of the thyroid-stimulating hormone α gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9114 9118 2-s2.0-0024357987 10.1073/pnas.86.23.9114 (Pubitemid 20010375)
90. Seoane S., Alonso M., Segura C., Pérez-Fernández R., Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochemical and Biophysical Research Communications 2002 292 1 250 255 10.1006/bbrc.2002.6641 (Pubitemid 34687356)
91. Weisz A., Coppola L., Bresciani F., Specific binding of estrogen receptor to sites upstream and within the transcribed region of the chicken ovalbumin gene. Biochemical and Biophysical Research Communications 1986 139 2 396 402 2-s2.0-0022489647 (Pubitemid 16002445)
92. La Baer J., Yamamoto K. R., Analysis of the DNA-binding affinity, sequence specificity and context dependence of the glucocorticoid receptor zinc finger region. Journal of Molecular Biology 1994 239 5 664 688 2-s2.0-0028359720 10.1006/jmbi.1994.1405 (Pubitemid 24202391)
93. Claessens F., Gewirth D. T., DNA recognition by nuclear receptors. Essays in Biochemistry 2004 40 59 72 2-s2.0-3142760881 (Pubitemid 38906672)
94. Tsai S. Y., Carlstedt-Duke J., Weigel N. L., Dahlman K., Gustafsson J. A., Tsai M. J., O'Malley B. W., Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 1988 55 2 361 369 2-s2.0-0023700693
95. Klinge C. M., Bodenner D. L., Desai D., Niles R. M., Traish A. M., Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in Vitro. Nucleic Acids Research 1997 25 10 1903 1912 2-s2.0-0030787494 10.1093/nar/25.10.1903 (Pubitemid 27303384)
96. Ribeiro R. C. J., Feng W., Wagner R. L., Costa C. H. R. M., Pereira A. C., Apriletti J. W., Fletterick R. J., Baxter J. D., Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. Journal of Biological Chemistry 2001 276 18 14987 14995 2-s2.0-0035805580 10.1074/jbc.M010195200
97. Brelivet Y., Kammerer S., Rochel N., Poch O., Moras D., Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level. EMBO Reports 2004 5 4 423 429 2-s2.0-2442560527 10.1038/sj.embor.7400119 (Pubitemid 38618287)
98. Lee S., Privalsky M. L., Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Molecular Endocrinology 2005 19 4 863 878 2-s2.0-15444378492 10.1210/me.2004-0210 (Pubitemid 40397052)
99. Powell E., Xu W., Intermolecular interactions identify ligand-selective activity of estrogen receptor α / β dimers. Proceedings of the National Academy of Sciences of the United States of America 2008 105 48 19012 19017 2-s2.0-57749105457 10.1073/pnas.0807274105
100. Wilson T. E., Fahrner T. J., Milbrandt J., The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Molecular and Cellular Biology 1993 13 9 5794 5804 2-s2.0-0027305861 (Pubitemid 23260680)
101. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor super-family: the second decade. Cell 1995 83 6 835 839 2-s2.0-0012473279
102. Danielsen M., Hinck L., Ringold G. M., Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 1989 57 7 1131 1138 2-s2.0-0024356431 (Pubitemid 19169809)
103. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., Claessens F., Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. Journal of Biological Chemistry 2000 275 16 12298 12305 2-s2.0-0034697359 10.1074/jbc.275.16.12298 (Pubitemid 30237811)
104. Shaffer P. L., Jivan A., Dollins D. E., Claessens F., Gewirth D. T., Structural basis of androgen receptor binding to selective androgen response elements. Proceedings of the National Academy of Sciences of the United States of America 2004 101 14 4758 4763 2-s2.0-1842637389 10.1073/pnas.0401123101 (Pubitemid 38469150)
105. Denayer S., Helsen C., Thorrez L., Haelens A., Claessens F., The rules of DNA recognition by the androgen receptor. Molecular Endocrinology 2010 24 5 898 913 2-s2.0-77953027535 10.1210/me.2009-0310
106. Aslam F., Shalhoub V., Van Wijnen A. J., Banerjee C., Bortell R., Shakoori A. R., Litwack G., Stein J. L., Stein G. S., Lian J. B., Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Molecular Endocrinology 1995 9 6 679 690 2-s2.0-0029030725
107. Ou X. M., Storring J. M., Kushwaha N., Albert P. R., Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. Journal of Biological Chemistry 2001 276 17 14299 14307 2-s2.0-0035958021
108. Ruiz M. M. V., Bugge T. H., Hirschmann P., Stunnenberg H. G., Functional characterization of a natural retinoic acid responsive element. EMBO Journal 1991 10 12 3829 3838 2-s2.0-0026052251 (Pubitemid 21905411)
109. Casas F., Daury L., Grandemange S., Busson M., Seyer P., Hatier R., Carazo A., Cabello G., Wrutniak-Cabello C., Endocrine regulation of mitochondrial activity: involvement of truncated RXR α and c-Erb a α 1 proteins. FASEB Journal 2003 17 3 426 436 2-s2.0-0037334906 10.1096/fj.02-0732com (Pubitemid 36292958)
110. Williams G. R., Zavacki A. M., Harney J. W., Brent G. A., Thyroid hormone receptor binds with unique properties to response elements that contain hexamer domains in an inverted palindrome arrangement. Endocrinology 1994 134 4 1888 1896 2-s2.0-0028262261 10.1210/en.134.4.1888 (Pubitemid 24110752)
111. Ikeda M., Rhee M., Chin W. W., Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements. Endocrinology 1994 135 4 1628 1638 2-s2.0-0028094947 10.1210/en.135.4.1628 (Pubitemid 24307543)
112. Hirst M. A., Hinck L., Danielsen M., Ringold G. M., Discrimination of DNA response elements for thyroid hormone and estrogen is dependent on dimerization of receptor DNA binding domains. Proceedings of the National Academy of Sciences of the United States of America 1992 89 12 5527 5531 2-s2.0-0026773439 10.1073/pnas.89.12.5527
113. Towers T. L., Luisi B. F., Asianov A., Freedman L. P., DNA target selectivity by the vitamin D3 receptor: mechanism of dimer binding to an asymmetric repeat element. Proceedings of the National Academy of Sciences of the United States of America 1993 90 13 6310 6314 2-s2.0-0027299443 (Pubitemid 23191505)
114. Miyamoto T., Suzuki S., DeGroot L. J., High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation. Molecular Endocrinology 1993 7 2 224 231 2-s2.0-0027405803 10.1210/me.7.2.224 (Pubitemid 23066865)
115. Miyamoto T., Suzuki S., DeGroot L. J., Differential binding and activation of thyroid hormone response elements by TR(α 1) and RXR(α)-trap heterodimers. Molecular and Cellular Endocrinology 1994 102 1-2 111 117 2-s2.0-0028242655 10.1016/0303-7207(94)90104-X
116. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L. J., Grippo J. F., Hunziker W., Two nuclear signalling pathways for vitamin D. Nature 1993 361 6413 657 660 2-s2.0-0027528947 10.1038/361657a0 (Pubitemid 23062402)
117. Yan Z. H., Medvedev A., Hirose T., Gotoh H., Jetten A. M., Characterization of the response element and DNA binding properties of the nuclear orphan receptor germ cell nuclear factor/retinoid receptor- related testis-associated receptor. Journal of Biological Chemistry 1997 272 16 10565 10572 2-s2.0-1842293921 10.1074/jbc.272.16.10565 (Pubitemid 27181063)
118. Schule R., Umesono K., Mangelsdorf D. J., Bolado J., Pike J. W., Evans R. M., Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990 61 3 497 504 2-s2.0-0025331086 10.1016/0092-8674(90)90531-I (Pubitemid 20169004)
119. Lazar M. A., Berrodin T. J., Thyroid hormone receptors form distinct nuclear protein-dependent and independent complexes with a thyroid hormone response element. Molecular Endocrinology 1990 4 11 1627 1635 2-s2.0-0025683224
120. Faisst S., Meyer S., Compilation of vertebrate-encoded transcription factors. Nucleic Acids Research 1992 20 1 3 26 2-s2.0-0026508808
121. Kirfel J., Kelter M., Cancela L. M., Price P. A., Schüle R., Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. Proceedings of the National Academy of Sciences of the United States of America 1997 94 6 2227 2232 2-s2.0-0030992162 10.1073/pnas.94.6.2227 (Pubitemid 27136856)
122. Eubank D. W., Duplus E., Williams S. C., Forest C., Beale E. G., Peroxisome proliferator-activated receptor γ and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. Journal of Biological Chemistry 2001 276 32 30561 30569 2-s2.0-0035839502 10.1074/jbc.M103019200
123. 3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Molecular Endocrinology 2007 21 2 334 342 2-s2.0-33846658748 10.1210/me.2006-0231 (Pubitemid 46188281)
124. Guigon C. J., Kim D. W., Zhu X., Zhao L., Cheng S. Y., Tumor suppressor action of liganded thyroid hormone receptor β by direct repression of β -catenin gene expression. Endocrinology 2010 151 11 5528 5536 2-s2.0-78049499915 10.1210/en.2010-0475
125. Harding H. P., Lazar M. A., The orphan receptor Rev-ErbA α activates transcription via a novel response element. Molecular and Cellular Biology 1993 13 5 3113 3121 2-s2.0-0027230076 (Pubitemid 23133982)
126. Giguere V., Tini M., Flock G., Ong E., Evans R. M., Otulakowski G., Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR α a novel family of orphan hormone nuclear receptors. Genes and Development 1994 8 5 538 553 2-s2.0-0028197552
127. Pratt W. B., Toft D. O., Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrine Reviews 1997 18 3 306 360 2-s2.0-0030925683 10.1210/er.18.3.306 (Pubitemid 27246880)
128. Graumann K., Jungbauer A., Quantitative assessment of complex formation of nuclear-receptor accessory proteins. Biochemical Journal 2000 345 3 627 636 2-s2.0-0034141351 10.1042/0264-6021:3450627 (Pubitemid 30099093)
129. Rajapandi T., Greene L. E., Eisenberg E., The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor. Journal of Biological Chemistry 2000 275 29 22597 22604 2-s2.0-0034698087 10.1074/jbc.M002035200 (Pubitemid 30621853)
130. Cintron N. S., Toft D., Defining the requirements for Hsp40 and Hsp70 in the Hsp90 chaperone pathway. Journal of Biological Chemistry 2006 281 36 26235 26244 2-s2.0-33748747967 10.1074/jbc.M605417200 (Pubitemid 44401831)
131. Schülke J. P., Wochnik G. M., Lang-Rollin I., Gassen N. C., Knapp R. T., Berning B., Yassouridis A., Rein T., Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PloS one 2010 5 7, article e11717 2-s2.0-78049385146 10.1371/journal.pone.0011717
132. Nishi M., Kawata M., Dynamics of glucocorticoid receptor and mineralocorticoid receptor: implications from live cell imaging studies. Neuroendocrinology 2007 85 3 186 192 2-s2.0-34249950662 10.1159/000101917 (Pubitemid 46878908)
133. Kawata M., Nishi M., Matsuda K., Sakamoto H., Kaku N., Masugi-Tokita M., Fujikawa K., Hirahara-Wada Y., Takanami K., Mori H., Steroid receptor signalling
134. Elbi C., Walker D. A., Romero G., Sullivan W. P., Toft D. O., Hager G. L., DeFranco D. B., Molecular chaperones function as steroid receptor nuclear mobility factors. Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 2876 2881 2-s2.0-1542267822 10.1073/pnas.0400116101 (Pubitemid 38327704)
135. Spencer T. E., Jenster G., Burcin M. M., Allis C. D., Zhou J., Mizzen C. A., McKenna N. J., Onate S. A., Tsai S. Y., Tsai M. J., O'Malley B. W., Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997 389 6647 194 198 2-s2.0-0030768745 10.1038/38304 (Pubitemid 27400603)
136. Liu Z., Wong J., Tsai S. Y., Tsai M. J., O'Malley B. W., Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12426 12431 2-s2.0-0035940497 10.1073/pnas. 231474798 (Pubitemid 33019962)
137. Kim M. Y., Hsiao S. J., Kraus W. L., A role for coactivators and histone acetylation in estrogen receptor α -mediated transcription initiation. EMBO Journal 2001 20 21 6084 6094 2-s2.0-0035503476 10.1093/emboj/20.21.6084 (Pubitemid 33049283)
138. Belandia B., Orford R. L., Hurst H. C., Parker M. G., Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO Journal 2002 21 15 4094 4103 2-s2.0-0036683485 10.1093/emboj/cdf412 (Pubitemid 34857441)
139. Kang Z., Jänne O. A., Palvimo J. J., Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Molecular Endocrinology 2004 18 11 2633 2648 2-s2.0-8344272750 10.1210/me.2004-0245 (Pubitemid 39482054)
140. van de Wijngaart D. J., Dubbink H. J., van Royen M. E., Trapman J., Jenster G., Androgen receptor coregulators: recruitment via the coactivator binding groove. Molecular and Cellular Endocrinology 2012 352 1-2 57 69 10.1016/j.mce.2011.08.007
141. Pearce D., Matsui W., Miner J. N., Yamamoto K. R., Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. Journal of Biological Chemistry 1998 273 46 30081 30085 2-s2.0-0032515034 10.1074/jbc.273.46.30081 (Pubitemid 28545467)
142. Kushner P. J., Agard D. A., Greene G. L., Scanlan T. S., Shiau A. K., Uht R. M., Webb P., Estrogen receptor pathways to AP-1. Journal of Steroid Biochemistry and Molecular Biology 2000 74 5 311 317 2-s2.0-0034735861 10.1016/S0960-0760(00)00108-4 (Pubitemid 32126243)
143. Takai H., Nakayama Y., Kim D. S., Arai M., Araki S., Mezawa M., Nakajima Y., Kato N., Masunaga H., Ogata Y., Androgen receptor stimulates bone sialoprotein (BSP) gene transcription via cAMP response element and activator protein 1/glucocorticoid response elements. Journal of Cellular Biochemistry 2007 102 1 240 251 2-s2.0-34548515482 10.1002/jcb.21297 (Pubitemid 47378925)
144. Konig H., Ponta H., Rahmsdorf H. J., Herrlich P., Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO Journal 1992 11 6 2241 2246 2-s2.0-0026579203
145. Gionet N., Jansson D., Mader S., Pratt M. A. C., NF- B and estrogen receptor α interactions: differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Journal of Cellular Biochemistry 2009 107 3 448 459 2-s2.0-66749103282 10.1002/jcb.22141
146. Rao N. A., McCalman M. T., Moulos P., Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Research 2011 21 9 1404 1416 10.1101/gr.118042.110
147. Chen J. D., Evans R. M., A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995 377 6548 454 457 2-s2.0-0029097233
148. Hörlein A. J., Näär A. M., Heinzel T., Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995 377 6548 397 404 10.1038/377397a0
149. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G., Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal 1995 14 15 3741 3751 2-s2.0-0029121358
150. Fernandes I., Bastien Y., Wai T., Nygard K., Lin R., Cormier O., Lee H. S., Eng F., Bertos N. R., Pelletier N., Mader S., Han V. K. M., Yang X. J., White J. H., Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Molecular Cell 2003 11 1 139 150 2-s2.0-0037248643 10.1016/S1097-2765(03)00014-5 (Pubitemid 36126597)
151. Augereau P., Badia E., Carascossa S., The nuclear receptor transcriptional coregulator RIP140. Nuclear Receptor Signaling 2006 4, article e024
152. Subramaniam N., Cairns W., Okret S., Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. Journal of Biological Chemistry 1998 273 36 23567 23574 2-s2.0-0032483406 10.1074/jbc.273.36.23567 (Pubitemid 28417550)
153. Wilson M. A., Chrysogelos S. A., Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells. Journal of Cellular Biochemistry 2002 85 3 601 614 2-s2.0-0036237676 10.1002/jcb.10168 (Pubitemid 34465140)
154. Govindan M. V., Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription. Journal of Biological Chemistry 2010 285 7 4489 4510 2-s2.0-77951163565 10.1074/jbc.M109.072728
155. Prüfer K., Barsony J., Retinoid X Receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Molecular Endocrinology 2002 16 8 1738 1751 2-s2.0-0036020491 10.1210/me.2001-0345 (Pubitemid 34828085)
156. Cao X., Liu W., Lin F., Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting. Molecular and Cellular Biology 2004 24 22 9705 9725 10.1128/MCB.24.22.9705-9725. 2004 (Pubitemid 39458800)
157. Yu V. C., Delsert C., Andersen B., Holloway J. M., Devary O. V., Näär A. M., Kim S. Y., Boutin J. M., Glass C. K., Rosenfeld M. G., RXR β: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991 67 6 1251 1266 2-s2.0-0026342117 (Pubitemid 121001537)
158. Puzianowska-Kuznicka M., Damjanovski S., Shi Y. B., Both thyroid hormone and 9- cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis. Molecular and Cellular Biology 1997 17 8 4738 4749 2-s2.0-0030853945 (Pubitemid 27318149)
159. Laflamme L., Hamann G., Messier N., Maltais S., Langlois M. F., RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. Journal of Molecular Endocrinology 2002 29 1 61 72 2-s2.0-0036668569 10.1677/jme.0.0290061 (Pubitemid 34965746)
160. Lefebvre P., Benomar Y., Staels B., Retinoid X receptors: common heterodimerization partners with distinct functions. Trends in Endocrinology and Metabolism 2010 21 11 676 683 2-s2.0-78049278719 10.1016/j.tem.2010.06.009
161. Mader S., Chen J. Y., Chen Z., White J., Chambon P., Gronemeyer H., The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO Journal 1993 12 13 5029 5041 2-s2.0-0027381438 (Pubitemid 23358491)
162. Force W. R., Tillman J. B., Sprung C. N., Spindler S. R., Homodimer and heterodimer DNA binding and transcriptional responsiveness to triiodothyronine (T3) and 9-cis-retinoic acid are determined by the number and order of high affinity half-sites in a T3 response element. Journal of Biological Chemistry 1994 269 12 8863 8871 2-s2.0-0028247138
163. Morin B., Nichols L. A., Holland L. J., Flanking sequence composition differentially affects the binding and functional characteristics of glucocorticoid receptor homo- and heterodimers. Biochemistry 2006 45 23 7299 7306 2-s2.0-33745070996 10.1021/bi060314k (Pubitemid 43880315)
164. Perlmann T., Rangarajan P. N., Umesono K., Evans R. M., Determinants for selective RAR and TR recognition of direct repeat HREs. Genes and Development 1993 7 7 1411 1422 2-s2.0-0027237598 (Pubitemid 23210889)
165. Kurokawa R., Yu V. C., Naar A., Kyakumoto S., Han Z., Silverman S., Rosenfeld M. G., Glass C. K., Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes and Development B 1993 7 7 1423 1435 2-s2.0-0027202156 (Pubitemid 23210890)
166. Kurokawa R., DiRenzo J., Boehm M., Sugarman J., Gloss B., Rosenfeld M. G., Heyman R. A., Glass C. K., Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 1994 371 6497 528 531 2-s2.0-0028122988 10.1038/371528a0 (Pubitemid 24306612)
167. Ijpenberg A., Jeannin E., Wahli W., Desvergne B., Polarity and specific sequence requirements of peroxisome proliferator- activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. Journal of Biological Chemistry 1997 272 32 20108 20117 2-s2.0-0030818756 10.1074/jbc.272.32.20108 (Pubitemid 27340117)
168. Ferrara J., McCuaig K., Hendy G. N., Uskokovic M., White J. H., Highly potent transcriptional activation by 16-ene derivatives of 1,25- dihydroxyvitamin D3. Lack of modulation by 9- cis -retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives. Journal of Biological Chemistry 1994 269 4 2971 2981 2-s2.0-0028074545
169. Forman B. M., Umesono K., Chen J., Evans R. M., Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995 81 4 541 550 2-s2.0-0029002298
170. Li D., Yamada T., Wang F., Vulin A. I., Samuels H. H., Novel roles of retinoid X receptor (RXR) anal RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer. Journal of Biological Chemistry 2004 279 9 7427 7437 2-s2.0-1542379985 10.1074/jbc.M311596200 (Pubitemid 38294619)
171. Chen J. Y., Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Reczek P. R., Chambon P., Gronemeyer H., Two distinct actions of retinoid-receptor ligands. Nature 1996 382 6594 819 822 2-s2.0-0029781068 10.1038/382819a0 (Pubitemid 26299567)
172. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M., Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 1992 358 6389 771 774 2-s2.0-0026705751 10.1038/358771a0
173. Antonio V., Janvier B., Brouillet A., Andreani M., Raymondjean M., Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochemical Journal 2003 376 2 351 360 2-s2.0-0348147584 10.1042/BJ20030098 (Pubitemid 38010519)
174. Zamir I., Dawson J., Lavinsky R. M., Glass C. K., Rosenfeld M. G., Lazar M. A., Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14400 14405 2-s2.0-0031460228 10.1073/pnas.94.26.14400 (Pubitemid 28041385)
175. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., Tenbaum S. P., Renkawitz R., Baniahmad A., Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Molecular and Cellular Biology 1999 19 5 3383 3394 2-s2.0-0032933431 (Pubitemid 29193798)
176. Watson P. J., Fairall L., Schwabe J. W., Nuclear hormone receptor co-repressors: structure and function. Molecular and Cellular Endocrinology 2012 348 2 440 449 10.1016/j.mce.2011.08.033
177. Kwok R. P. S., Lundblad J. R., Chrivia J. C., Richards J. P., Bachinger H. P., Brennan R. G., Roberts S. G. E., Green M. R., Goodman R. H., Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994 370 6486 223 226 2-s2.0-0028060029 10.1038/370223a0 (Pubitemid 24236779)
178. Lundblad J. R., Kwok R. P. S., Laurance M. E., Harter M. L., Goodman R. H., Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 1995 374 6517 85 88 2-s2.0-0028985162
179. Onate S. A., Tsai S. Y., Tsai M. J., O'Malley B. W., Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995 270 5240 1354 1357 2-s2.0-0028846193
180. Voegel J. J., Heine M. J. S., Zechel C., Chambon P., Gronemeyer H., TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 1996 15 14 3667 3675 2-s2.0-0029954339 (Pubitemid 26239779)
181. Fondell J. D., Ge H., Roeder R. G., Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8329 8333 2-s2.0-0029758906 10.1073/pnas.93.16.8329 (Pubitemid 26269557)
182. Yang X. J., Ogryzko V. V., Nishikawa J. I., Howard B. H., Nakatani Y., A p300/CPB-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996 382 6589 319 324 2-s2.0-0029665857 10.1038/382319a0 (Pubitemid 26260451)
183. Takeshita A., Cardona G. R., Koibuchi N., Suen C. S., Chin W. W., TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. Journal of Biological Chemistry 1997 272 44 27629 27634 2-s2.0-0030786270 10.1074/jbc.272.44.27629 (Pubitemid 27473556)
184. Puigserver P., Wu Z., Park C. W., Graves R., Wright M., Spiegelman B. M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998 92 6 829 839 2-s2.0-0032549811 10.1016/S0092-8674(00) 81410-5 (Pubitemid 28155321)
185. Rachez C., Suldan Z., Ward J., Chang C. P. B., Burakov D., Erdjument-Bromage H., Tempst P., Freedman L. P., A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes and Development 1998 12 12 1787 1800 2-s2.0-0032525781 (Pubitemid 28304332)
186. Kim H. J., Yi J. Y., Sung H. S., Moore D. D., Jhun B. H., Lee Y. C., Lee J. W., Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation. Molecular and Cellular Biology 1999 19 9 6323 6332 2-s2.0-0032771843 (Pubitemid 29399337)
187. Lee S. K., Anzick S. L., Choi J. E., Bubendorf L., Guan X. Y., Jung Y. K., Kallioniemi O. P., Kononen J., Trent J. M., Azorsa D., Jhun B. H., Cheong J. H., Lee Y. C., Meltzer P. S., Lee J. W., A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. Journal of Biological Chemistry 1999 274 48 34283 34293 2-s2.0-0033607672 10.1074/jbc.274.48.34283 (Pubitemid 129511770)
188. Wu Y., Delerive P., Chin W. W., Burris T. P., Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1. Journal of Biological Chemistry 2002 277 11 8898 8905 2-s2.0-0037088644 10.1074/jbc.M110761200 (Pubitemid 34952959)
189. York B., O'Malley B. W., Steroid Receptor Coactivator (SRC) family: masters of systems biology. Journal of Biological Chemistry 2010 285 50 38743 38750 2-s2.0-78649846415 10.1074/jbc.R110.193367
190. Salbert G., Fanjul A., Piedrafita F. J., Xian Ping Lu, Kim S. J., Tran P., Pfahl M., Retinoic acid receptors and retinoid X receptor- α down-regulate the transforming growth factor- β 1 promoter by antagonizing AP-1 activity. Molecular Endocrinology 1993 7 10 1347 1356 2-s2.0-0027521292 10.1210/me.7.10.1347 (Pubitemid 23319118)
191. Harant H., Andrew P. J., Reddy G. S., Foglar E., Lindley I. J. D., 1 α25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor- B-mediated interleukin-8 gene expression. European Journal of Biochemistry 1997 250 1 63 71 2-s2.0-0030608964 (Pubitemid 27504583)
192. Barrera-Hernandez G., Zhan Q., Wong R., Cheng S. Y., Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA and Cell Biology 1998 17 9 743 750 2-s2.0-0031707153 (Pubitemid 28462873)
193. Xu J., Thompson K. L., Shephard L. B., Hudson L. G., Gill G. N., T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. Journal of Biological Chemistry 1993 268 21 16065 16073 2-s2.0-0027338196 (Pubitemid 23222115)
194. D'Ambrosio D., Cippitelli M., Cocciolo M. G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F., Panina-Bordignon P., Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF- B downregulation in transcriptional repression of the p40 gene. Journal of Clinical Investigation 1998 101 1 252 262 2-s2.0-0031974910 (Pubitemid 28058925)
195. Potter G. B., Beaudoin G. M. J. III, DeRenzo C. L., Zarach J. M., Chen S. H., Thompson C. C., The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes and Development 2001 15 20 2687 2701 2-s2.0-0035887252 10.1101/gad.916701 (Pubitemid 32988879)
196. Moraitis A. N., Giguère V., Thompson C. C., Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Molecular and Cellular Biology 2002 22 19 6831 6841 2-s2.0-0036786432 10.1128/MCB.22.19.6831-6841.2002
197. Hsieh J. C., Sisk J. M., Jurutka P. W., Haussler C. A., Slater S. A., Haussler M. R., Thompson C. C., Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. Journal of Biological Chemistry 2003 278 40 38665 38674 2-s2.0-0141961566 10.1074/jbc.M304886200 (Pubitemid 37229065)
198. Epping M. T., Wang L., Edel M. J., Carlée L., Hernandez M., Bernards R., The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 2005 122 6 835 847 2-s2.0-25144503301 10.1016/j.cell.2005.07.003 (Pubitemid 41345202)
199. Hashimoto K., Yamada M., Matsumoto S., Monden T., Satoh T., Mori M., Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology 2006 147 9 4292 4302 2-s2.0-33747591214 10.1210/en.2006-0116 (Pubitemid 44268380)
200. Blanco J. C. G., Wang I. M., Tsai S. Y., Tsai M. J., O'Malley B. W., Jurutka P. W., Haussler M. R., Ozato K., Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proceedings of the National Academy of Sciences of the United States of America 1995 92 5 1535 1539 2-s2.0-0028950983 10.1073/pnas.92.5.1535
201. Fondell J. D., Brunel F., Hisatake K., Roeder R. G., Unliganded thyroid hormone receptor α can target TATA-binding protein for transcriptional repression. Molecular and Cellular Biology 1996 16 1 281 287 2-s2.0-0029656208 (Pubitemid 126506973)
202. Mcewan I. J., Gustafsson J., Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proceedings of the National Academy of Sciences of the United States of America 1997 94 16 8485 8490 2-s2.0-0030790495 10.1073/pnas.94.16.8485 (Pubitemid 27335065)
203. Wärnmark A., Wikström A., Wright A. P. H., Gustafsson J. Å., Härd T., The N-terminal Regions of Estrogen Receptor α and β are Unstructured in Vitro and Show Different TBP Binding Properties. Journal of Biological Chemistry 2001 276 49 45939 45944 2-s2.0-0035824562 10.1074/jbc.M107875200
204. Reid J., Murray I., Watt K., Betney R., McEwan I. J., The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF. Journal of Biological Chemistry 2002 277 43 41247 41253 2-s2.0-0037174886 10.1074/jbc.M205220200 (Pubitemid 35221330)
205. Khan S. H., Ling J., Kumar R., TBP binding-induced folding of the Glucocorticoid receptor AF1 domain facilitates its interaction with Steroid Receptor Coactivator-1. PLoS ONE 2011 6 7, article e21939 2-s2.0-79960066455 10.1371/journal.pone.0021939 e21939
206. Heery D. M., Kalkhoven E., Hoare S., Parker M. G., A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997 387 6634 733 736 2-s2.0-0030986236 10.1038/42750 (Pubitemid 27270617)
207. Bannister A. J., Kouzarides T., The CBP co-activator is a histone acetyltransferase. Nature 1996 384 6610 641 643 2-s2.0-0030480969 10.1038/384641a0 (Pubitemid 27021517)
208. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y., The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996 87 5 953 959 2-s2.0-0030606239 10.1016/S0092-8674(00)82001-2 (Pubitemid 26404293)
209. Shao W., Rosenauer A., Mann K., Chang C. P. B., Rachez C., Freedman L. P., Miller W. H., Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells. Blood 2000 96 6 2233 2239 2-s2.0-0034665889
210. Perissi V., Staszewski L. M., McInerney E. M., Kurokawa R., Krones A., Rose D. W., Lambert M. H., Milburn M. V., Glass C. K., Rosenfeld M. G., Molecular determinants of nuclear receptor-corepressor interaction. Genes and Development 1999 13 24 3198 3208 2-s2.0-0033572656 10.1101/gad.13.24.3198 (Pubitemid 30030442)
211. Webb P., Anderson C. M., Valentine C., Nguyen P., Marimuthu A., West B. L., Baxter J. D., Kushner P. J., The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Molecular Endocrinology 2000 14 12 1976 1985 2-s2.0-0034536085 10.1210/me.14.12.1976 (Pubitemid 32055531)
212. Guenther M. G., Barak O., Lazar M. A., The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Molecular and Cellular Biology 2001 21 18 6091 6101 2-s2.0-0035724413 10.1128/MCB.21.18.6091-6101.2001 (Pubitemid 34263509)
213. Codina A., Love J. D., Li Y., Lazar M. A., Neuhaus D., Schwabe J. W. R., Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proceedings of the National Academy of Sciences of the United States of America 2005 102 17 6009 6014 2-s2.0-17844371338 10.1073/pnas.0500299102 (Pubitemid 40594246)
214. Montano M. M., Ekena K., Delage-Mourroux R., Chang W., Martini P., Katzenellenbogen B. S., An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proceedings of the National Academy of Sciences of the United States of America 1999 96 12 6947 6952 2-s2.0-0033536054 10.1073/pnas.96.12.6947 (Pubitemid 29274990)
215. Mazumdar A., Wang R. A., Mishra S. K., Adam L., Bagheri-Yarmand R., Mandal M., Vadlamudi R. K., Kumar R., Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biology 2001 3 1 30 37 2-s2.0-0035146442 10.1038/35050532 (Pubitemid 32114829)
216. Huang N., Vom Baur E., Garnier J. M., Lerouge T., Vonesch J. L., Lutz Y., Chambon P., Losson R., Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO Journal 1998 17 12 3398 3412 2-s2.0-0032526951 10.1093/emboj/17.12.3398 (Pubitemid 28279513)
217. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A., Baldwin A. S., Characterization of mechanisms involved in transrepression of NF- B by activated glucocorticoid receptors. Molecular and Cellular Biology 1995 15 2 943 953 2-s2.0-0028831128
218. Yap N., Yu C. L., Cheng S. Y., Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proceedings of the National Academy of Sciences of the United States of America 1996 93 9 4273 4277 2-s2.0-0029978846 10.1073/pnas.93.9.4273 (Pubitemid 26144276)
219. Préfontaine G. G., Walther R., Giffin W., Lemieux M. E., Pope L., Haché R. J. G., Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. Journal of Biological Chemistry 1999 274 38 26713 26719 2-s2.0-0039108033 10.1074/jbc.274.38.26713 (Pubitemid 29440006)
220. Delerive P., De Bosscher K., Besnard S., Berghe W. V., Peters J. M., Gonzalez F. J., Fruchart J. C., Tedgui A., Haegeman G., Staels B., Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF- B and AP-1. Journal of Biological Chemistry 1999 274 45 32048 32054 2-s2.0-0033527569 10.1074/jbc.274.45.32048 (Pubitemid 29522941)
221. Wang L. H., Yang X. Y., Zhang X., Transcriptional inactivation of STAT3 by PPARg suppresses IL-6-responsive multiple myeloma cells. Immunity 2004 20 2 205 218 10.1016/S1074-7613(04)00030-5 (Pubitemid 38258396)
222. Kim H. P., Lee J. Y., Jeong J. K., Bae S. W., Lee H. K., Jo I., Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochemical and Biophysical Research Communications 1999 263 1 257 262 2-s2.0-0344549854 10.1006/bbrc.1999.1348 (Pubitemid 29443672)
223. Lu M. L., Schneider M. C., Zheng Y., Zhang X., Richie J. P., Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. Journal of Biological Chemistry 2001 276 16 13442 13451 2-s2.0-0035918165 10.1074/jbc.M006598200
224. 3 in vivo and in Vitro. Molecular Endocrinology 2004 18 11 2660 2671 2-s2.0-8344254362 10.1210/me.2004-0116 (Pubitemid 39482056)
225. Matthews L., Berry A., Ohanian V., Ohanian J., Garside H., Ray D., Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Molecular Endocrinology 2008 22 6 1320 1330 2-s2.0-44649200612 10.1210/me.2007-0154 (Pubitemid 351786993)
226. Mousa S. A., O'Connor L. J., Bergh J. J., Davis F. B., Scanlan T. S., Davis P. J., The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. Journal of Cardiovascular Pharmacology 2005 46 3 356 360 2-s2.0-24344506562 10.1097/01.fjc.0000175438.94906.a0 (Pubitemid 41262839)
227. Karteris E., Zervou S., Pang Y., Dong J., Hillhouse E. W., Randeva H. S., Thomas P., Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Molecular Endocrinology 2006 20 7 1519 1534 2-s2.0-33745672495 10.1210/me.2005-0243 (Pubitemid 43967561)
228. Smith J. L., Kupchak B. R., Garitaonandia I., Heterologous expression of human mPR α mPR β and mPR γ in yeast confirms their ability to function as membrane progesterone receptors. Steroids 2008 73 11 1160 1173 10.1016/j.steroids.2008.05.003
229. '-monophosphate. Journal of Clinical Endocrinology and Metabolism 1990 71 2 398 404 2-s2.0-0025108824
230. Nakhla A. M., Leonard J., Hryb D. J., Rosner W., Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids 1999 64 3 213 216 2-s2.0-0033020144 10.1016/S0039-128X(98)00084-1 (Pubitemid 29283674)
231. Mitchell E. A., Herd M. B., Gunn B. G., Lambert J. J., Belelli D., Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochemistry International 2008 52 4-5 588 595 2-s2.0-38549166646 10.1016/j.neuint.2007.10.007 (Pubitemid 351146675)
232. Acconcia F., Ascenzi P., Bocedi A., Spisni E., Tomasi V., Trentalance A., Visca P., Marino M., Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17 β -estradiol. Molecular Biology of the Cell 2005 16 1 231 237 2-s2.0-11144332004 10.1091/mbc.E04-07-0547 (Pubitemid 40028339)
233. Li L., Haynes M. P., Bender J. R., Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4807 4812 2-s2.0-0037446887 10.1073/pnas.0831079100 (Pubitemid 36457810)
234. Figtree G. A., McDonald D., Watkins H., Channon K. M., Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003 107 1 120 126 2-s2.0-0037422527 10.1161/01.CIR.0000043805.11780.F5 (Pubitemid 36070943)
235. Wang Z., Zhang X., Shen P., Loggie B. W., Chang Y., Deuel T. F., A variant of estrogen receptor- α hER- α 36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9063 9068 2-s2.0-33745160700 10.1073/pnas.0603339103 (Pubitemid 43902533)
236. Razandi M., Pedram A., Levin E. R., Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Molecular and Cellular Biology 2010 30 13 3249 3261 2-s2.0-77953460074 10.1128/MCB.01354-09
237. Pedram A., Razandi M., Deschenes R. J., Levin E. R., DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Molecular Biology of the Cell 2012 23 1 188 199 10.1091/mbc.E11-07-0638
238. Pedram A., Razandi M., Sainson R. C. A., Kim J. K., Hughes C. C., Levin E. R., A conserved mechanism for steroid receptor translocation to the plasma membrane. Journal of Biological Chemistry 2007 282 31 22278 22288 2-s2.0-34547928773 10.1074/jbc.M611877200 (Pubitemid 47267344)
239. Bondar G., Kuo J., Hamid N., Micevych P., Estradiol-induced estrogen receptor- α trafficking. Journal of Neuroscience 2009 29 48 15323 15330 2-s2.0-72849152546 10.1523/JNEUROSCI.2107-09.2009
240. Buitrago C., Boland R., Caveolae and caveolin-1 are implicated in 1 α25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. Journal of Steroid Biochemistry and Molecular Biology 2010 121 1-2 169 175 2-s2.0-77954762255 10.1016/j.jsbmb.2010. 03.002
241. Bennett N., Hooper J. D., Lee C. S., Gobe G. C., Androgen receptor and caveolin-1 in prostate cancer. IUBMB Life 2009 61 10 961 970 2-s2.0-73349118472 10.1002/iub.244
242. Zhao G., Simpson R. U., Membrane localization, Caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes. Steroids 2010 75 8-9 555 559 2-s2.0-77954244766 10.1016/j.steroids.2009.12.001
243. Schwartz Z., Ehland H., Sylvia V. L., Larsson D., Hardin R. R., Bingham V., Lopez D., Dean D. D., Boyan B. D., 1 α25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 2002 143 7 2775 2786 2-s2.0-0035984118 10.1210/en.143.7.2775 (Pubitemid 34701342)
244. Vicencio J. M., Ibarra C., Estrada M., Chiong M., Soto D., Parra V., Diaz-Araya G., Jaimovich E., Lavandero S., Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 2006 147 3 1386 1395 2-s2.0-32644453029 10.1210/en.2005-1139 (Pubitemid 43244373)
245. Storey N. M., Gentile S., Ullah H., Russo A., Muessel M., Erxleben C., Armstrong D. L., Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America 2006 103 13 5197 5201 2-s2.0-33645514600 10.1073/pnas.0600089103
246. Zamoner A., Heimfarth L., Loureiro S. O., Royer C., Silva F. R. M. B., Pessoa-Pureur R., Nongenomic actions of thyroxine modulate intermediate filament phosphorylation in cerebral cortex of rats. Neuroscience 2008 156 3 640 652 2-s2.0-53249107182 10.1016/j.neuroscience.2008.07.059
247. Elbaradie K., Wang Y., Boyan B. D., Schwartz Z., Rapid membrane responses to dihydrotestosterone are sex dependent in growth plate chondrocytes. Journal of Steroid Biochemistry and Molecular Biology 2012 132 1-2 15 23 10.1016/j.jsbmb.2011.12.009
248. 3 stimulation of secretion via chloride channel activation in Sertoli cells. Journal of Steroid Biochemistry and Molecular Biology 2010 119 3-5 127 134 2-s2.0-77950297294 10.1016/j.jsbmb.2010.01.011
249. + currents in rat medial preoptic neurons. PLoS ONE 2011 6 5, article e20213 2-s2.0-79956324829 10.1371/journal.pone.0020213 e20213
250. Simoncini T., Hafezi-Moghadam A., Brazil D. P., Ley K., Chin W. W., Llao J. K., Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000 407 6803 538 541 2-s2.0-0034727094 10.1038/35035131
251. Pietrzak M., Puzianowska-Kuznicka M., Triiodothyronine utilizes phosphatidylinositol 3-kinase pathway to activate anti-apoptotic myeloid cell leukemia-1. Journal of Molecular Endocrinology 2008 41 3-4 177 186 2-s2.0-55749099782 10.1677/JME-08-0010
252. Yan T. D., Wu H., Zhang H. P., Oncogenic potential of retinoic acid receptor g in hepatocellular carcinoma. Cancer Research 2010 70 6 2285 2295 10.1158/0008-5472.CAN-09-2968
253. Boonyaratanakornkit V., Scott M. P., Ribon V., Sherman L., Anderson S. M., Maller J. L., Miller W. T., Edwards D. P., Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Molecular Cell 2001 8 2 269 280 2-s2.0-0034852802 10.1016/S1097-2765(01)00304-5 (Pubitemid 32831545)
254. Migliaccio A., Varricchio L., De Falco A., Castoria G., Arra C., Yamaguchi H., Ciociola A., Lombardi M., Di Stasio R., Barbieri A., Baldi A., Barone M. V., Appella E., Auricchio F., Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 2007 26 46 6619 6629 2-s2.0-34648849274 10.1038/sj.onc.1210487 (Pubitemid 47573684)
255. Cheskis B. J., Greger J., Cooch N., McNally C., Mclarney S., Lam H. S., Rutledge S., Mekonnen B., Hauze D., Nagpal S., Freedman L. P., MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids 2008 73 9-10 901 905 2-s2.0-44549086936 10.1016/j.steroids.2007.12.028
256. García-Pedrero J. M., Rio B. D., Martínez-Campa C., Muramatsu M., Lazo P. S., Ramos S., Calmodulin is a selective modulator of estrogen receptors. Molecular Endocrinology 2002 16 5 947 960 2-s2.0-0036246318 10.1210/me.16.5.947 (Pubitemid 34478533)
257. 2+/calmodulin. Journal of Biological Chemistry 2005 280 13 13097 13104 2-s2.0-16844372082 10.1074/jbc.M410642200
258. Hentschke M., Schulze C., Süsens U., Borgmeyer U., Characterization of calmodulin binding to the orphan nuclear receptor ERR γ Biological Chemistry 2003 384 3 473 482 2-s2.0-0037625758 10.1515/BC.2003.053 (Pubitemid 36531463)
259. Cifuentes E., Mataraza J. M., Yoshida B. A., Menon M., Sacks D. B., Barrack E. R., Reddy G. P. V., Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2004 101 2 464 469 2-s2.0-0347635517 10.1073/pnas.0307161101 (Pubitemid 38084659)
260. Alzamora R., Brown L. R., Harvey B. J., Direct binding and activation of protein kinase C isoforms by aldosterone and 17 β -estradiol. Molecular Endocrinology 2007 21 11 2637 2650 2-s2.0-35648946319 10.1210/me.2006-0559 (Pubitemid 350035147)
261. Alzamora R., Harvey B. J., Direct binding and activation of protein kinase C isoforms by steroid hormones. Steroids 2008 73 9-10 885 888 2-s2.0-44649132655 10.1016/j.steroids.2008.01.001
262. Demonacos C., Tsawdaroglou N. C., Djordjevic-Markovic R., Papalopoulou M., Galanopoulos V., Papadogeorgaki S., Sekeris C. E., Import of the glucocorticoid receptor into rat liver mitochondria in vivo and in Vitro. Journal of Steroid Biochemistry and Molecular Biology 1993 46 3 401 413 2-s2.0-0027365579 10.1016/0960-0760(93)90231-K (Pubitemid 23284499)
263. Wrutniak C., Cassar-Malek I., Marchal S., Rascle A., Heusser S., Keller-J. M., Flechon J., Dauca M., Samarut J., Ghysdael J., Cabello G., A 43-kDa protein related to c-Erb A α 1 is located in the mitochondrial matrix of rat liver. Journal of Biological Chemistry 1995 270 27 16347 16354 2-s2.0-0028999361 10.1074/jbc.270.27.16347
264. Casas F., Domenjoud L., Rochard P., Hatier R., Rodier A., Daury L., Bianchi A., Kremarik-Bouillaud P., Becuwe P., Keller J. M., Schohn H., Wrutniak-Cabello C., Cabello G., Dauça M., A 45 kDa protein related to PPAR γ 2, induced by peroxisome proliferators, is located in the mitochondrial matrix. FEBS Letters 2000 478 1-2 4 8 2-s2.0-0034725984 10.1016/S0014-5793(00)01814-7 (Pubitemid 30462248)
265. Chen J. Q., Eshete M., Alworth W. L., Yager J. D., Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors α and β to human mitochondrial DNA estrogen response elements. Journal of Cellular Biochemistry 2004 93 2 358 373 2-s2.0-9644267549 10.1002/jcb.20178 (Pubitemid 44264212)
266. Arnold S., Goglia F., Kadenbach B., 3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. European Journal of Biochemistry 1998 252 2 325 330 2-s2.0-0032031485 (Pubitemid 28102010)
267. Notario B., Zamora M., Viñas O., Mampel T., All- trans -retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition. Molecular Pharmacology 2003 63 1 224 231 2-s2.0-0037221034 10.1124/mol.63.1.224 (Pubitemid 36043826)
268. Sterling K., Brenner M. A., Thyroid hormone action: effect of triiodothyronine on mitochondrial adenine nucleotide translocase in vivo and in Vitro. Metabolism 1995 44 2 193 199 2-s2.0-0028899694
269. Lin B., Kolluri S. K., Lin F., Liu W., Han Y. H., Cao X., Dawson M. I., Reed J. C., Zhang X. K., Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004 116 4 527 540 2-s2.0-1342306819 10.1016/S0092-8674(04)00162-X (Pubitemid 38264430)
270. 2+ efflux from synaptosomal mitochondria. General Physiology and Biophysics 2000 19 1 59 71
271. 2+ siqnaling by ligand stimulated thyroid hormone receptor. Journal of Cell Biology 2004 167 5 915 924 2-s2.0-10344266986 10.1083/jcb.200409011 (Pubitemid 39628113)
272. Zhang L., Zhou R., Li X., Ursano R. J., Li H., Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Medical Hypotheses 2006 66 6 1205 1208 2-s2.0-33645216575 10.1016/j.mehy.2005.11.041
273. Poon M. M., Chen L., Retinoic acid-gated sequence-specific translational control by RAR α Proceedings of the National Academy of Sciences of the United States of America 2008 105 51 20303 20308 2-s2.0-58149503693 10.1073/pnas.0807740105
274. Buttgereit F., Scheffold A., Rapid glucocorticoid effects on immune cells. Steroids 2002 67 6 529 534 2-s2.0-0036224429 10.1016/S0039-128X(01)00171- 4 (Pubitemid 34311770)
275. Panin L. E., Mokrushnikov P. V., Kunitsyn V. G., Zaitsev B. N., Interaction mechanism of cortisol and catecholamines with structural components of erythrocyte membranes. Journal of Physical Chemistry B 2010 114 29 9462 9473 2-s2.0-77954944583 10.1021/jp911917a